{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:41:18Z","timestamp":1763728878211,"version":"3.40.5"},"reference-count":94,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1080\/14712598.2024.2413365","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T11:27:04Z","timestamp":1728041224000},"page":"1233-1244","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["The role of antibody therapies in treating relapsed chronic lymphocytic leukemia: a review"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3942-0753","authenticated-orcid":false,"given":"Magdalena","family":"Witkowska","sequence":"first","affiliation":[{"name":"Department of Hematology, Medical University of Lodz, Lodz, Poland"},{"name":"Department of Hemato-oncology, Copernicus Memorial Hospital, Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Majchrzak","sequence":"additional","affiliation":[{"name":"Department of General Hematology, Copernicus Memorial Hospital, Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6078-5415","authenticated-orcid":false,"given":"Pawe\u0142","family":"Robak","sequence":"additional","affiliation":[{"name":"Department of Hematology, Medical University of Lodz, Lodz, Poland"},{"name":"Department of Hemato-oncology, Copernicus Memorial Hospital, Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8838-2098","authenticated-orcid":false,"given":"Anna","family":"Wolska-Washer","sequence":"additional","affiliation":[{"name":"Department of Hematology, Medical University of Lodz, Lodz, Poland"},{"name":"Department of Hemato-oncology, Copernicus Memorial Hospital, Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-6357","authenticated-orcid":false,"given":"Tadeusz","family":"Robak","sequence":"additional","affiliation":[{"name":"Department of Hematology, Medical University of Lodz, Lodz, Poland"},{"name":"Department of General Hematology, Copernicus Memorial Hospital, Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041720"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.019"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282632"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21595"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature15395"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432602"},{"issue":"101","key":"e_1_3_7_11_1","first-page":"5","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente XS","year":"2011","unstructured":"Puente XS, Pinyol M, Quesada V, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 2011;475(101):5.","journal-title":"Nature"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184427"},{"issue":"1249","key":"e_1_3_7_13_1","first-page":"65","article-title":"Novel synthetic drugs currently in clinical development for chronic lymphocytic leukemia","volume":"26","author":"Robak P","year":"2017","unstructured":"Robak P, Robak T. Novel synthetic drugs currently in clinical development for chronic lymphocytic leukemia. Expert Opin Investig Drugs. 2017;26(1249):65.","journal-title":"Expert Opin Investig Drugs"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.4556"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01001-1"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.96"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0306"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.4103\/2229-516X.149245"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.124107"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2016.02.010"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.243543"},{"key":"e_1_3_7_22_1","first-page":"676","article-title":"Mechanisms of action of CD20 antibodies","volume":"2","author":"Boross P","year":"2012","unstructured":"Boross P, Leusen JH. Mechanisms of action of CD20 antibodies. Am J Cancer Res. 2012;2:676\u2013690.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200211002-00002"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2010.01.011"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61381-5"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-651125"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.2688"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08597.x"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.8061"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0797"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.266486"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713976"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2023.2288899"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2024.2368175"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-879429"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812836"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00465-9"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315226"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30671-4"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1948038"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0451-1"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313984"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2023.2216327"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17326"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0554-1"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-01-896290"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-05-853564"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00211-3"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-173708"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01854-z"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30433-6"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147460"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134783"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0964"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111021"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-111781"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1122783"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1233536"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285043"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1964020"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02635-9"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12103041"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23890"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403822"},{"key":"e_1_3_7_65_1","first-page":"1383","article-title":"TRU-016, a humanized anti-CD37 IgG fusion protein for the potential treatment of B-cell malignancies","volume":"10","author":"Robak T","year":"2009","unstructured":"Robak T, Robak P, Smolewski P. TRU-016, a humanized anti-CD37 IgG fusion protein for the potential treatment of B-cell malignancies. Curr Opin Invest Drugs (Lond Engl. 2009;10:1383\u20131390.","journal-title":"Curr Opin Invest Drugs (Lond Engl"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-512137"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14464"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-020-01056-4"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2001.01163.x"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0710-1"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.08.011"},{"key":"e_1_3_7_72_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102725"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2095"},{"key":"e_1_3_7_74_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3412"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.46989\/001c.88382"},{"key":"e_1_3_7_76_1","first-page":"145","article-title":"Chimeric antigen receptor T Cell therapy for acute leukemia","volume":"6","author":"Pan J","year":"2023","unstructured":"Pan J. Chimeric antigen receptor T Cell therapy for acute leukemia. Blood Cell Ther. 2023;6:145\u2013150.","journal-title":"Blood Cell Ther"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.082248"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01649-3"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02329"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2018.05.018"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.7527"},{"key":"e_1_3_7_82_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-159586"},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009517"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03175"},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594556"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1211220"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-0692"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018029371"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2022.00112"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00172"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081917"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70128-2"},{"key":"e_1_3_7_93_1","first-page":"4129","article-title":"A phase I study of the anti-CD79b THIOMABTM-drug conjugate DCDS0780A in patients (pts) with relapsed or refractory B-cell non-hodgkin\u2019s lymphoma (B-NHL)","volume":"130","author":"Herrera AF","year":"2017","unstructured":"Herrera AF, Patel MR, Burke JM, et al. A phase I study of the anti-CD79b THIOMABTM-drug conjugate DCDS0780A in patients (pts) with relapsed or refractory B-cell non-hodgkin\u2019s lymphoma (B-NHL). Blood. 2017;130:4129.","journal-title":"Blood"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.02.010"},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031589"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2300696"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2024.2413365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T06:45:09Z","timestamp":1732862709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2024.2413365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":94,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1080\/14712598.2024.2413365"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2024.2413365","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"type":"print","value":"1471-2598"},{"type":"electronic","value":"1744-7682"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}